Phospho-valproic acid (MDC-1112) reduces pancreatic cancer growth in patient-derived tumor xenografts and KPC mice: enhanced efficacy when combined with gemcitabine-论文-万方医学网

首页> > Phospho-valproic acid (MDC-1112) reduces pancreatic cancer growth in patient-derived tumor xenografts and KPC mice: enhanced efficacy when combined with gemcitabine

Phospho-valproic acid (MDC-1112) reduces pancreatic cancer growth in patient-derived tumor xenografts and KPC mice: enhanced efficacy when combined with gemcitabine

导出原文传递

翻译打印收藏纠错

第一作者： Luo, Dingyuan

作者： Luo, Dingyuan ^[1] ; DiGiovanni, Matthew G. ^[2] ; Wei, Ran ^[3] ; LaComb, Joseph F. ; Williams, Jennie L. ; Rigas, Basil ; Mackenzie, Gerardo G.

作者单位： SUNY Stony Brook, Dept Family Populat & Prevent Med, Stony Brook, NY 11794 USA ^[1] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA ^[2] Univ Calif Davis, Dept Nutr, One Shields Ave, Davis, CA 95616 USA ^[3]

发布时间 2021-01-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Phospho-valproic acid (MDC-1112) reduces pancreatic cancer growth in patient-derived tumor xenografts and KPC mice: enhanced efficacy when combined with gemcitabine

相似文献

同项目论文

相关期刊

检索历史 清除

Phospho-valproic acid (MDC-1112) reduces pancreatic cancer growth in patient-derived tumor xenografts and KPC mice: enhanced efficacy when combined with gemcitabine

相似文献

同项目论文

相关期刊

检索历史清除